Opioid receptor agonist Eribris peptide 94 reduces infarct size in different porcine models of myocardial ischemia and reperfusion. Poster accepted at ESC congress in Stockholm.
You are here: News >> Poster accepted at ESC congress in Stockholm
Opioid receptor agonist Eribris peptide 94 reduces infarct size in different porcine models of myocardial ischemia and reperfusion. Poster accepted at ESC congress in Stockholm.
| Copyright © Eribis Pharmaceuticals. Developed by dreamforce.se. This web site uses cookies. Read more. |